Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.9900 (-8.55%) ($5.5600 - $6.3900) on Fri. May. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 33.82% (three month average) | RSI | 84 | Latest Price | $5.9900(-8.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XOP(34%) OIH(33%) DIA(29%) XLE(29%) IVE(27%) | Factors Impacting CAPR price | CAPR will decline at least -16.91% in a week (0% probabilities). VIXM(-26%) VXX(-24%) TLT(-19%) UUP(-15%) BND(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -16.91% (StdDev 33.82%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
5 Day Moving Average | $7.06(-15.16%) | 10 Day Moving Average | $7.02(-14.67%) | 20 Day Moving Average | $5.51(8.71%) | To recent high | -29.5% | To recent low | 0% | Market Cap | $118m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |